Ballons ACT chez la femme : évolution de l’efficacité au cours des 24 mois suivant l’implantation

Abstract

To analyze the functional outcomes over time of ACT balloon in women with stress urinary incontinence (SUI) secondary to intrinsic sphincter deficiency (ISD). All patients with SUI secondary to ISD who underwent bilateral ACT balloon implantation between September 2008and November 2015and regularly monitored for a period of at least 24months were eligible. The results were studied at 6, 12and 24months. Efficacy was defined as: Success - maximum 1safety pad per day and visual analogue scale (VAS) rating≥9/10. Improvement - decrease in the number of pads used per day and VAS≥5/10. Failure - increase or stability of the number of pads used per day and/or VAS<5/10. Failure was considered as primary when it occurred without any success or improvement. It was considered as secondary when it occurred after an initial period of success or improvement. 18patients were monitored during 24months. The success rate was respectively 17%, 33% and 33% at 6, 12and 24months of follow-up. The improvement rate was respectively 61%, 39% and 17% at 6, 12and 24months of follow-up. The primary failure rate was 22%. The secondary failure rate was 6% at 12months and 33% at 24months of follow-up. ACT balloon efficacy tends to decrease with time requiring a long-term follow-up of implanted patients. 4.